Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients. [electronic resource]
- European journal of endocrinology Jul 2013
- 117-26 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1479-683X
10.1530/EJE-13-0299 doi
Adult Aged Cardiovascular Diseases--mortality Cause of Death Cohort Studies Confounding Factors, Epidemiologic Diabetes Mellitus, Type 2--drug therapy Drug Therapy, Combination Female Follow-Up Studies Gliclazide--therapeutic use Glyburide--therapeutic use Humans Hypoglycemic Agents--administration & dosage Insulin--therapeutic use Kaplan-Meier Estimate Male Metformin--therapeutic use Middle Aged Neoplasms--mortality Odds Ratio Proportional Hazards Models Research Design Retrospective Studies Risk Assessment Risk Factors Sulfonylurea Compounds--administration & dosage Tolbutamide--therapeutic use